Dr. Ross Fitzgerald
University of Edinburgh, United Kingdom

Dr. Ross Fitzgerald is Senior Lecturer in Bacteriology at the Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh. After completing a PhD at Trinity College, Dublin on the population genetics of the major pathogen Staphylococcus aureus, he carried out post-doctoral studies on S. aureus comparative genomics in the NIH with Dr. Jim Musser, and on the role of surface proteins in S. aureus pathogenesis with Prof. Tim Foster in Dublin. He was appointed to a lectureship at the University of Edinburgh in 2004 and established the Laboratory for Bacterial Evolution and Pathogenesis which is focussed on the evolution and pathogenesis of clinically important species of staphylococci such as S. aureus and the Staphylococcus intermedius group including Staphylococcus pseudintermedius, the major cause of canine pyoderma. He is using genome sequencing approaches to investigate pathogenesis and host-specificity and to identify novel therapeutic targets.


 

 

 


Dr. Ross Fitzgerald
University of Edinburgh, United Kingdom

Dr. Ross Fitzgerald is Senior Lecturer in Bacteriology at the Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh. After completing a PhD at Trinity College, Dublin on the population genetics of the major pathogen Staphylococcus aureus, he carried out post-doctoral studies on S. aureus comparative genomics in the NIH with Dr. Jim Musser, and on the role of surface proteins in S. aureus pathogenesis with Prof. Tim Foster in Dublin. He was appointed to a lectureship at the University of Edinburgh in 2004 and established the Laboratory for Bacterial Evolution and Pathogenesis which is focussed on the evolution and pathogenesis of clinically important species of staphylococci such as S. aureus and the Staphylococcus intermedius group including Staphylococcus pseudintermedius, the major cause of canine pyoderma. He is using genome sequencing approaches to investigate pathogenesis and host-specificity and to identify novel therapeutic targets.